Phase 2 studies of oral hypoxia-inducible factor prolyl hydroxylase inhibitor FG-4592 for treatment of anemia in China
在中国开展的口服缺氧诱导因子脯氨酰羟化酶抑制剂FG-4592治疗贫血的II期临床研究
期刊:Nephrology Dialysis Transplantation
影响因子:5.6
doi:10.1093/ndt/gfx011
Chen, Nan; Qian, Jiaqi; Chen, Jianghua; Yu, Xueqing; Mei, Changlin; Hao, Chuanming; Jiang, Gengru; Lin, Hongli; Zhang, Xinzhou; Zuo, Li; He, Qiang; Fu, Ping; Li, Xuemei; Ni, Dalvin; Hemmerich, Stefan; Liu, Cameron; Szczech, Lynda; Besarab, Anatole; Neff, Thomas B; Peony Yu, Kin-Hung; Valone, Frank H